Compliance team reviewing documents and a laptop around a meeting table

Resources

Practical insight for
compliance in motion.

Explore Eunomia’s articles, webinars, case studies and working resources — brought together in one place.

Find the right starting point

Which pharma compliance resource do you need?

Use the articles to understand a topic, the worksheets to organise a task and the case studies to see how a defined engagement was delivered. Each serves a different purpose. Adapt working templates to your organisation’s markets, responsibilities and approved procedures.

Choose a resource by the task on your desk
Your taskStart herePractical output
Plan role-based learningTraining matrixTopic assignments, learning depth and evidence of application.
Assess an HCP feeFMV assessment worksheetA record of service need, assumptions and rate rationale.
Prepare disclosure dataDisclosure preparation guideOwnership, reconciliation checks and methodological-note prompts.
Improve material reviewPromotional review workflowSubmission steps, responsibilities and release controls.

How should you use the sources?

Read the scope notes alongside each article’s references. An official code or law establishes its own requirements; a worksheet provides a suggested way to organise the work. Check the current source and the relevant national rules before applying guidance to an activity. Case-study outcomes describe specific engagements, rather than results every organisation should expect.

For implementation support, explore programme design and implementation or outsourced compliance operations.

Eunomia perspectives

Articles & insights

38 perspectives on operational compliance, transparency, governance and technology.

01

EU AI Act Governance & Article 50: A Practical Guide for Pharma

02

Pharma Compliance Across the Product Lifecycle

03

The EU AI Act for Pharmaceutical Companies: What Applies and When

04

Disclosure UK: How It Works, Deadlines, Consent and Objections

05

EFPIA Disclosure Requirements and Template, Explained

06

Failure to Prevent Fraud: What Pharmaceutical Companies Need to Do

07

The ABPI Signatory: Certification Requirements, Role and Training

08

Lessons from Recent PMCPA Cases: What 2026 Rulings Mean for Your Processes

09

Managing Healthcare Professionals’ Personal Data under GDPR: CRM, FMV and Engagement Records

10

GDPR and Transparency Reporting: Disclosing HCP Transfers of Value

11

How Small and Mid-Sized Pharma Companies Can Build an Effective Compliance Risk Assessment Framework

12

Top Transparency Reporting Mistakes Pharmaceutical Companies Should Avoid

13

PMCPA’s 2026 Social Media Guidance: Compliance Priorities Companies Should Address Now

14

Right-Sized Compliance Support: Meeting the Needs of Both Emerging Biotech and Global Pharma

15

Navigating Country-Level Accountability in Europe: A Key Pillar of Healthcare Compliance

16

Scalable Compliance Models for Growing Pharma in the Age of AI

17

Entering Phase III? Compliance Expectations Already Have

18

From Risk to Resilience: Why Third-Party Risk Management Is Pharma’s Biggest Competitive Advantage

19

Compliance Gap Analysis: Reducing Risk Without Slowing Growth

20

Sunshine Act in France: Understanding the Transparency in Healthcare System

21

Transparency Reporting in the Pharmaceutical Industry: Legal Compliance Versus Ethical Responsibility

22

Fair Market Value (FMV) in Healthcare Compliance: Turning Regulatory Expectation into an Operational Capability

23

Beyond the Checklist: How Gap Analysis Strengthens Healthcare Compliance Internal Audits

24

Digitalisation in Pharma: Strengthening Healthcare Compliance Through Smart Systems & Integrated Governance

25

 Staying Ahead of the Curve: Audit-Readiness Best Practices Across European Life Sciences Markets

26

Top 10 Healthcare Compliance Challenges in Pharma Industry and How to Solve Them

27

What Makes Healthcare Compliance Training Effective?

28

How to Avoid Common Healthcare Compliance Mistakes in Pharmaceuticals

29

AI in Healthcare Compliance: Navigating Opportunities, Risks, and Regulatory Landscapes

30

Compliance Training: Beyond the Code

31

A Definitive Guide to Crafting a high-quality Policy for a Pharmaceutical Company

32

Stakeholder Engagement vs Risk: EFPIA & IFPMA Compliance

33

Risk Assessment in Healthcare and its Importance

34

The Future of Diversity & Inclusion in Pharma Compliance: A European Perspective

35

Unleash the Power of Data Analytics for Healthcare Compliance

36

Importance of Bespoke Healthcare Compliance Training for Pharmaceutical Industry

37

Managing compliance Risks: Best Practices & Strategies

38

Staying Ahead in Healthcare Compliance: Navigating AI Challenges with Ethical Governance

Questions, answered

About our resources

Are the resources free?

Yes. Articles and case studies are free to read. The practical Excel worksheets can be downloaded directly. Some PDF checklists and guides use a request form so we can send the file.

How are the articles sourced?

Each article opens with a short answer and ends with its sources. Legal and code statements link to the official text, such as EUR-Lex, legislation.gov.uk, the PMCPA or EFPIA.

Are these resources legal advice?

No. They are practical, informational guidance. Requirements depend on your organisation, markets and activities, and should be confirmed for your situation.

Where can I find country-specific rules?

Our country guides cover Germany, France, Spain, Italy, the Netherlands, Portugal, Ireland and Sweden, each with links to official sources. They are listed on the Legal Mandates page.